Bellicum Pharmaceuticals, Inc. BLCM
Set alert
As of Mar 4, 2:59 PM ET
52-week range unavailable
- Open
- 0.0801
- Prev close
- 0.07475
- Mkt cap
- 3.51M
- Vol
- 6.06K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0717
- High
- 0.09
- Forward P/E
- -0.39
- Beta
- 1.51
- Short ratio
- 0.17
- Inst. own
- 29.30%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 5, 2024
- 50-d avg
- 0.524896
- 200-d avg
- 0.816478
- 1y target
- 5.00
News
-
3 years ago benzinga.com
Why Capri Holdings Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company announced it received agreement from the FDA on its proposed single confirmatory Phase 3 study of…
-
3 years ago benzinga.com
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China.
-
3 years ago benzinga.com
Why Bellicum Pharmaceuticals Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket
Gainers Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) gained 105.2% to $0.8001 in pre-market trading. Bellicum Pharmaceuticals 13D filing showed Baker Bros. Advisors reported a 19.99% active stake in…
-
3 years ago benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
12 Health Care Stocks Moving In Thursday's Intraday Session
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 469 companies hit new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 74 companies achieved new lows for the year.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 198 companies hit new 52-week lows.
3 years ago zacks.com
Bellicum (BLCM) Down on Ending Development of CAR-T Candidates
Following the decision to discontinue the development of pipeline candidates, Bellicum Pharmaceuticals (BLCM) is left with no candidate in clinical development. The stock is down 50% post the news.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 479 stocks made new 52-week lows.
-
3 years ago benzinga.com
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.
-
3 years ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
3 years ago globenewswire.com
Bellicum Discontinues Phase 1/2 Trials and Initiates Evaluation of Strategic Alternatives
HOUSTON, March 14, 2023 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), today announced its decision to discontinue its ongoing Phase 1/2 clinical trials evaluating the safety and…
3 years ago zacks.com
Is Bellicum Pharmaceuticals (BLCM) Outperforming Other Medical Stocks This Year?
Here is how Bellicum Pharmaceuticals (BLCM) and Castle Biosciences, Inc. (CSTL) have performed compared to their sector so far this year.
3 years ago globenewswire.com
CORRECTION -- Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HOUSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) -- In a release issued earlier today by Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), please note that the total number of stock options should be 20,000, not…
3 years ago globenewswire.com
Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HOUSTON, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced equity…
-
3 years ago benzinga.com
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force.
3 years ago globenewswire.com
Bellicum Pharmaceuticals to Present Early Phase 1 Results for BPX-601 in Prostate Cancer at ASCO 2023 Genitourinary Cancers Symposium
HOUSTON, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that an…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 293 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 241 companies hit new 52-week lows.
3 years ago globenewswire.com
Bellicum Announces Presentation by UNC at ASH 2022 on Potential Abrogation of iC9 CAR T-Cell Toxicities with Rimiducid
HOUSTON, Dec. 11, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced a poster…
4 years ago globenewswire.com
Bellicum Pharmaceuticals to Participate in the 2022 Cell & Gene Meeting on the Mesa
HOUSTON, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick…
4 years ago globenewswire.com
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
HOUSTON, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick…
4 years ago globenewswire.com
Bellicum Reports Second Quarter 2022 Financial Results and Provides Operational Update
HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial…
4 years ago globenewswire.com
Bellicum Reports Fourth Quarter 2021 Financial Results and Provides Operational Update
- Confirmed partial response in one of the first three metastatic castration-resistant prostate cancer (mCRPC) patients treated with BPX-601 in Phase 1/2 study -
-
4 years ago benzinga.com
60 Biggest Movers From Yesterday
Gainers Inspirato Incorporated (NASDAQ: ISPO) shares climbed 618.2% to close at $92.65 on Thursday, just a few days after the company completed its SPAC merger with Thayer Ventures.
4 years ago globenewswire.com
Bellicum Pharmaceuticals to Participate in the B. Riley Securities 2022 Virtual Oncology Conference
HOUSTON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick…
4 years ago globenewswire.com
Bellicum Regains Compliance with Nasdaq Continued Listing Requirements
HOUSTON, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that it has…
4 years ago globenewswire.com
Bellicum Reports Third Quarter 2021 Financial Results and Provides Operational Update
- Entered into additional licensing agreement with The University of Texas MD Anderson Cancer Center for use of CaspaCIDe® safety switch technology -
5 years ago globenewswire.com
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
HOUSTON, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that Rick…
5 years ago pulse2.com
BLCM Stock: Over 12% Increase Pre-Market Explanation
The stock price of Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) increased over 12% pre-market. This is why it happened.
5 years ago globenewswire.com
Bellicum and MD Anderson Announce Additional License Agreement for Use of CaspaCIDe® Safety Switch
HOUSTON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, and The University of Texas…
5 years ago globenewswire.com
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HOUSTON, July 26, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced an equity…
5 years ago globenewswire.com
Bellicum Enters License Agreement with UNC Lineberger and Mass General for Use of CaspaCIDe® Safety Switch
HOUSTON, June 28, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced it has…
5 years ago globenewswire.com
Bellicum Reports First Quarter 2021 Financial Results and Provides Operational Update
HOUSTON, May 17, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today reported financial…
-
6 years ago benzinga.com
96 Biggest Movers From Friday
Gainers Fuel Tech, Inc (NASDAQ: FTEK) shares climbed 93.6% to close at $0.91 on Friday after the company reported FUEL CHEM® demonstration orders from two new industrial power customers.
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Friday
-
7 years ago benzinga.com
Stocks That Hit 52-Week Lows Of Monday
Stocks That Hit 52-Week Lows Of Monday
-
7 years ago benzinga.com
Stocks That Fell Through 52-Week Lows Wednesday
Stocks That Fell Through 52-Week Lows Wednesday
-
7 years ago benzinga.com
Stocks That Broke Yearly Lows Tuesday Morning
Stocks That Broke Yearly Lows Tuesday Morning
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018
Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 29th
Stocks Which Set New 52-Week Low Yesterday, October 29th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Friday, October 26th
Stocks Which Set New 52-Week Low Friday, October 26th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 23rd
Stocks Which Set New 52-Week Low Yesterday, October 23rd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 22nd
Stocks Which Set New 52-Week Low Yesterday, October 22nd